TTK Healthcare Ltd.

1490.95 +16.95 ▲1.2%

28 March 2024, 04:01:00 PM
Volume: 51

Company Profile

Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Industry Icon Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.ttkhealthcare.com
Market Cap 2,105.00 Cr.
Enterprise Value(EV) 1,261.22 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) 46.00 Trailing Twelve Months Ending 2023-12
Price-Earning Ratio (PE) 32.39 Trailing Twelve Months Ending 2023-12
Industry PE 41.15 Trailing Twelve Months Ending 2023-12
Book Value / Share 694.14 Trailing Twelve Months Ending 2023-12
Price to Book Value 2.15 Calculated using Price: 1,490.95
Dividend Yield 0.67 Period Ending 2023-03
No. of Shares Subscribed 1.41 Cr. 14,130,333 Shares
FaceValue 10
About TTK Healthcare Ltd.
T T K Healthcare Ltd was incorporated in 1958 and went public in the same year. The company's brand wagon consists of products that are sought after by a wide range of customers. The Woodward's Gripe Water brand is the market leader in the baby care category. The Eva range of personal care products (Talc, Deodorant, Skincare) bring together the gentle touch of nature, backed by TTK's extensive research.

TTK Healthcare Ltd. Delivery

Delivered Qty
Traded Qty

TTK Healthcare Ltd. Performance

1 Day
+1.15%
1 Week
-1.58%
1 Month
+0.94%
3 Month
+5.67%
6 Month
+29.75%
1 Year
+41.62%
2 Year
+88.57%
5 Year
+125.80%
10 Year
+179.78%

TTK Healthcare Ltd. Fundamental Ratios

9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 14.94 18.46 13.16 9.52 10.25 5.01 13.76 6.02 7.01
Return on Capital Employed (%) 20.71 23.85 18.63 15.42 15.46 8.28 8.38 8.59 10.13
Return on Assets (%) 6.27 7.85 6.38 5.28 5.99 2.94 8.04 3.56 5.2

TTK Healthcare Ltd. Balance Sheet

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 118 136 157 233 251 249 295 330 953 972
Non Curr. Liab. 28 16 8 2 2 7 4 1 2 0
Curr. Liab. 129 150 120 168 157 172 189 199 211 205
Minority Int.
Equity & Liab. 275 303 285 403 411 427 488 551 1,166 1,177
Non Curr. Assets 109 119 118 147 139 129 113 102 99 101
Curr. Assets 166 184 167 256 272 298 375 425 1,066 1,077
Misc. Exp. not W/O
Total Assets 275 303 285 403 411 427 488 551 1,166 1,177

TTK Healthcare Ltd. Profit and Loss

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-12 Rs. Cr. TTM
Net Sales 483 519 528 578 628 646 476 599 725 752
Other Income 7 6 6 8 8 9 10 16 48 62
Total Income 489 524 534 585 636 655 486 616 773 814
Total Expenditure -453 -478 -489 -535 -578 -617 -457 -577 -694 -712
PBIDT 36 46 44 50 57 37 29 38 80 102
Interest -4 -3 -3 -5 -3 -3 -2 -3 -5 -3
Depreciation -6 -7 -12 -15 -15 -14 -13 -13 -13 -13
Taxation -10 -13 -10 -12 -15 -7 14 -6 -17 -22
Exceptional Items 8 2
PAT 16 23 19 18 24 12 37 19 45 65
Adjusted EPS 21 29 24 13 17 9 26 13 32 46

TTK Healthcare Ltd. Cash Flow

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 13 39 37 18 25 17 20 96 45 -26
Cash Fr. Inv. -15 -49 -27 5 -23 10 -13 -77 -30 33
Cash Fr. Finan. 2 3 -11 -23 -7 -31 -10 -17 -10 -12
Net Change 0 -7 0 0 -4 -4 -4 2 5 -6
Cash & Cash Eqvt 84 77 77 19 15 11 8 10 15 9

TTK Healthcare Ltd. Shareholding Pattern

9 Qtrs 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%) 2023-12 (%)
Promoter 74.56 74.56 74.56 74.56 74.56 74.56 74.56 74.56 74.56
Public 25.44 25.44 25.44 25.44 25.44 25.44 25.44 25.44 25.44
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

TTK Healthcare Ltd. Announcements

Wed, 27 Mar 2024
Closure of Trading Window
Closure of Trading Window - Audited Financial Results for the year ending March 31 2024.
Wed, 20 Mar 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Announcement under Reg 39(3) of SEBI (LODR) 2015 - Loss of Share Certificate
Mon, 11 Mar 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Announcement under Reg 39(3) of SEBI (LODR) 2015 - Loss of Share Certificates

TTK Healthcare Ltd. Technical Scans

Wed, 27 Mar 2024
High Delivery Percentage High Delivery Percentage
Close Within 52 Week High Zone Close Within 52 Week High Zone
Close Below Last Week Low Close Below Last Week Low
High Increase in 6 Months High Increase in 6 Months
High Increase in 1 Year High Increase in 1 Year

TTK Healthcare Ltd. Related Stocks

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 385,837.06 1,620.50 +0.8%
Cipla Ltd. 118,376.16 1,494.65 +1.9%
Dr. Reddy's Laboratories Ltd. 100,885.01 6,171.85 +2.0%
Zydus Lifesciences Ltd. 100,583.15 1,007.35 +0.8%
Mankind Pharma Ltd. 93,457.28 2,300.75 -1.5%
Apollo Hospitals Enterprise Ltd. 89,582.15 6,347.35 +1.9%
Divi's Laboratories Ltd. 89,323.54 3,452.55 +2.6%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 43.32 1,620.50 +0.8%
Cipla Ltd. Consolidated 2023-12 31.92 1,494.65 +1.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 19.30 6,171.85 +2.0%
Zydus Lifesciences Ltd. Consolidated 2023-12 33.82 1,007.35 +0.8%
Mankind Pharma Ltd. Consolidated 2023-12 54.11 2,300.75 -1.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 113.49 6,347.35 +1.9%
Divi's Laboratories Ltd. Consolidated 2023-12 64.59 3,452.55 +2.6%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 6.18 1,620.50 +0.8%
Cipla Ltd. Consolidated 2023-12 4.57 1,494.65 +1.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 3.75 6,171.85 +2.0%
Zydus Lifesciences Ltd. Consolidated 2023-12 5.20 1,007.35 +0.8%
Mankind Pharma Ltd. Consolidated 2023-12 10.52 2,300.75 -1.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 13.26 6,347.35 +1.9%
Divi's Laboratories Ltd. Consolidated 2023-12 6.85 3,452.55 +2.6%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,620.50 +0.8%
Cipla Ltd. Consolidated 2023-03 0.02 1,494.65 +1.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 6,171.85 +2.0%
Zydus Lifesciences Ltd. Consolidated 2023-03 0.07 1,007.35 +0.8%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 2,300.75 -1.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 6,347.35 +1.9%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,452.55 +2.6%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,620.50 +0.8%
Cipla Ltd. Consolidated 2023-03 12.85 1,494.65 +1.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,171.85 +2.0%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 1,007.35 +0.8%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,300.75 -1.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,347.35 +1.9%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,452.55 +2.6%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,620.50 +0.8%
Cipla Ltd. Consolidated 2023-03 12.85 1,494.65 +1.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,171.85 +2.0%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 1,007.35 +0.8%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,300.75 -1.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,347.35 +1.9%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,452.55 +2.6%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,620.50 +0.8%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,494.65 +1.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 6,171.85 +2.0%
Zydus Lifesciences Ltd. Consolidated 2023-03 17,237.40 1,007.35 +0.8%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 2,300.75 -1.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 6,347.35 +1.9%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,452.55 +2.6%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,620.50 +0.8%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,494.65 +1.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 6,171.85 +2.0%
Zydus Lifesciences Ltd. Consolidated 2023-03 2,001.90 1,007.35 +0.8%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 2,300.75 -1.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 6,347.35 +1.9%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,452.55 +2.6%

TTK Healthcare Ltd. FAQ's

What is TTK Healthcare share price?

Can I buy TTK Healthcare shares now?

What is the Dividend Yield of TTK Healthcare?

What is the Market Cap of TTK Healthcare?

What are the key metrics to analyse TTK Healthcare?

What is the 52 Week High and Low of TTK Healthcare?

What is the trend of TTK Healthcare share price?